Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01026571

Identification of Genetic Causes of Bicuspid Aortic Valve Disease

BAVgenetics is a partnership between Investigators at Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital dedicated to discovering the genetic causes of bicuspid aortic valve disease and associated aortic disease.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

14 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Boston Medical Center

Boston, Massachusetts, 02118, United States

About this study

The Investigators at BAVgenetics are dedicated to discovering the mechanisms of bicuspid aortic valve disease and why individual genetics seem to play such an important role in generation of this disease.

If you have, or have had, a bicuspid aortic valve, we seek your help in this effort by volunteering to donate DNA to the BAV Registry, so that this disease can be better understood and therapies for it can be developed.

The BAV Registry is comprised of patients who have donated DNA collected from saliva (spit) and have provided us with personal health information that tells us about their bicuspid aortic valve.

Individuals in the Registry have signed the consent form, filled out the medical history questionnaire and the authorization form, and provided DNA via our saliva sample kits.

We will send you the requisite forms so that you receive the most up-to-date information about the study as older forms may be outdated. We also need paper copies of the forms; therefore, we send all the forms via ground mail along with a pre-paid return envelope for your convenience.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any adult patient ≥ 14 years of age may be recruited regardless of gender, ethnicity or racial group.
  • Patients with a diagnosis of bicuspid aortic valve will be enrolled.
  • Patients who have had their bicuspid aortic valve previously replaced will also be enrolled.
  • Relatives of patients with a diagnosis of bicuspid aortic valve are also welcomed to be enrolled regardless if they have BAV or not, as it is helpful to examine the DNA of first degree relatives.

Exclusion criteria

  • Non-English speaking

Treatment and study plan

Primary outcomes

  1. Identification of genetic variants associated with the occurrence of bicuspid aortic valve disease

    Time frame: 20 years

Sponsors and collaborators

Lead sponsor

Boston University

Other

Collaborators

  • Brigham and Women's Hospital
  • Massachusetts General Hospital
  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: BAV Genetics

Important dates

Study start
2009
Primary completion
2029
Study completion
2030
First posted
Dec 4, 2009
Registry last updated
Apr 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.